The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis
S. D, Kleine N, Teopiz K, Di Vincenzo J, Ho R, Galibert S, Samra A, Zilm S, H. R, d’Andrea G, Gill H, Ceban F, Meshkat S, Wong S, Le G, Kwan A, Rosenblat J, Rhee T, Mansur R, McIntyre R. The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis. Expert Opinion On Pharmacotherapy 2024, 25: 5-14. PMID: 38164653, DOI: 10.1080/14656566.2023.2298340.Peer-Reviewed Original ResearchMajor depressive disorderPostpartum depressionDepressive disorderDrug Enforcement AgencyAvailable antidepressant medicationsAvailable clinical studiesTreatment of adultsPositive allosteric modulatorsOral antidepressantsAntidepressant medicationAntidepressant treatmentCommon complicationNeuroactive steroidsSignificant safety concernsClinical trialsEfficacy dataZuranoloneClinical studiesIndirect comparisonMental illnessAllosteric modulatorsMental healthAntidepressantsSafety concernsWomen
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply